TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 49 filers reported holding TOKAI PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $13,000 | -78.7% | 15,755 | -74.7% | 0.00% | – |
| Q4 2016 | $61,000 | +84.8% | 62,327 | +192.1% | 0.00% | – |
| Q3 2016 | $33,000 | -76.9% | 21,337 | -17.8% | 0.00% | – |
| Q2 2016 | $143,000 | +31.2% | 25,968 | +33.3% | 0.00% | – |
| Q1 2016 | $109,000 | -25.3% | 19,486 | +16.7% | 0.00% | – |
| Q4 2015 | $146,000 | +14.1% | 16,702 | +35.0% | 0.00% | – |
| Q3 2015 | $128,000 | -21.0% | 12,368 | +1.4% | 0.00% | – |
| Q2 2015 | $162,000 | -4.1% | 12,193 | -18.4% | 0.00% | – |
| Q1 2015 | $169,000 | -68.1% | 14,935 | -58.4% | 0.00% | – |
| Q4 2014 | $530,000 | – | 35,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 637,110 | $3,574,187,000 | 0.71% |
| Novo Holdings A/S | 470,946 | $2,642,000 | 0.29% |
| Perceptive Advisors | 485,338 | $2,723,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 812,200 | $4,556,000 | 0.23% |
| FNY Managed Accounts LLC | 6,438 | $36,117,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $271,000 | 0.06% |
| Alyeska Investment Group, L.P. | 315,757 | $1,771,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $34,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $337,000 | 0.01% |
| BlackRock Fund Advisors | 530,538 | $2,976,000 | 0.00% |